Fundamentals - AlphaKey Financial

Stock Fundamentals

Company Information

▼

Company Name

Duopharma Biotech Bhd

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

KLSE

ISIN: MYL7148OO009

Currency: MYR

Full Time Employees: 1,957

Phone: 60 3 3323 2759

Website: https://duopharmabiotech.com

Fiscal Year End: December

Description:

Duopharma Biotech Berhad, an investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally. The company offers consumer healthcare products, such as vitamins, minerals, and supplements, analgesics, eyecare, antacids, and skin care products; and generic drugs for various therapeutic classes, such as cardiovascular, dermatology, hormones, respiratory, sensory and nervous system, musculo-skeletal system, anti-infectives, and others. It also provides specialty pharmaceutical drugs for targeted conditions, biosimilar products, and medical devices and consumables to patients with conditions, including diabetes, cancer, cardiovascular, renal, and other diseases. The company's product portfolio includes covasc, crystorvas, and vytocor; lebreta, and krabeva; and unihepa, erysaa, bi-haemosol, and haemosol. In addition, it offers its products under the Champs, Flavettes, Eye Glo, Proviton, Naturalle, IRORO Nutreatment, and Uphamol brands. The company was formerly known as CCM Duopharma Biotech Berhad and changed its name to Duopharma Biotech Berhad in February 2019. The company was founded in 1978 and is based in Klang, Malaysia.

Address:

Jalan Seruling 59, Klang, Malaysia, 41200

Directors & Officers

▼

Name	Title	Year Born
Mr. Wan Amir-Jeffery Bin Wan Abdul Majid	CEO & Principal Executive Officer	1972
Ms. Rohayu Rosnani Binti Mohd Adanan	Chief Financial Officer	1979
Mr. Ibrahim Hussin Salleh	Chief Legal Officer & Group Company Secretary	1968
Ms. Sabrina Binti Haron	Chief Compliance Officer	1981
Mr. Krisnakumara Reddi	Chief Manufacturing & Sustainability Officer	1970
Mr. Shamsul Idham Bin A. Iahad	Chief Consumer Healthcare Officer	1974
Mr. Wan Ahmad Nizam Bin Wan Mohd. Salleh	Group Head of Risk Management & Integrity	1974
Ms. Priya Darshini Asokan	Chief Innovation Officer	1983

Shares Statistics

▼

Shares Outstanding: 961.94M

Shares Float: 450.07M

% Insiders: 264.10%

% Institutions: 7,259.20%

Valuation Metrics

▼

Enterprise Value: $1.55B

Trailing P/E: 16.13

Forward P/E: 13.66

Financial Highlights

▼

Market Cap: $1.43B

EBITDA: $154.62M

P/E Ratio: $22.99

PEG Ratio: $0.38

Book Value: $0.77

Dividend/Share: $0.04

Dividend Yield: 2.73%

Earnings/Share: $0.09

Profit Margin: 8.63%

Operating Margin: 14.20%

ROA (TTM): 5.32%

ROE (TTM): 1,159.56%

Revenue (TTM): $886.92M

Revenue/Share (TTM): $0.92

Earnings Growth (YOY): 21.40%

Revenue Growth (YOY): 1.60%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

▼

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

Earnings History

▼

Date	EPS Actual	EPS Estimate	Difference	Surprise %
Jun 30, 2026	N/A	N/A	N/A	N/A
Mar 31, 2026	N/A	N/A	N/A	N/A
Dec 31, 2025	0.02	N/A	N/A	N/A
Sep 30, 2025	0.02	N/A	N/A	N/A
Jun 30, 2025	0.02	N/A	N/A	N/A
Mar 31, 2025	0.03	N/A	N/A	N/A
Dec 31, 2024	0.02	N/A	N/A	N/A
Sep 30, 2024	0.02	N/A	N/A	N/A
Jun 30, 2024	0.02	N/A	N/A	N/A
Mar 31, 2024	0.02	N/A	N/A	N/A
Dec 31, 2023	0.01	N/A	N/A	N/A
Sep 30, 2023	0.01	N/A	N/A	N/A
Jun 30, 2023	0.01	N/A	N/A	N/A
Mar 31, 2023	0.02	N/A	N/A	N/A
Dec 31, 2022	0.02	N/A	N/A	N/A
Sep 30, 2022	0.02	N/A	N/A	N/A
Jun 30, 2022	0.02	N/A	N/A	N/A
Mar 31, 2022	0.02	N/A	N/A	N/A
Dec 31, 2021	0.02	N/A	N/A	N/A
Sep 30, 2021	0.02	N/A	N/A	N/A
Jun 30, 2021	0.02	N/A	N/A	N/A
Mar 31, 2021	0.02	N/A	N/A	N/A
Dec 31, 2020	0.02	N/A	N/A	N/A
Sep 30, 2020	0.02	N/A	N/A	N/A
Jun 30, 2020	0.02	N/A	N/A	N/A
Mar 31, 2020	0.01	N/A	N/A	N/A
Dec 31, 2019	0.01	N/A	N/A	N/A
Sep 30, 2019	0.02	N/A	N/A	N/A
Jun 30, 2019	0.02	N/A	N/A	N/A
Mar 31, 2019	0.02	N/A	N/A	N/A
Dec 31, 2018	0.02	N/A	N/A	N/A
Sep 30, 2018	0.01	N/A	N/A	N/A
Jun 30, 2018	0.01	N/A	N/A	N/A
Mar 31, 2018	0.01	N/A	N/A	N/A
Dec 31, 2017	0.01	N/A	N/A	N/A
Sep 30, 2017	0.01	N/A	N/A	N/A
Jun 30, 2017	0.01	N/A	N/A	N/A
Mar 31, 2017	0.01	N/A	N/A	N/A
Dec 31, 2016	0.01	N/A	N/A	N/A
Sep 30, 2016	0.01	N/A	N/A	N/A
Jun 30, 2016	0.00	N/A	N/A	N/A
Mar 31, 2016	0.01	N/A	N/A	N/A
Dec 31, 2015	0.03	N/A	N/A	N/A
Sep 30, 2015	0.02	N/A	N/A	N/A
Jun 30, 2015	0.01	N/A	N/A	N/A
Mar 31, 2015	0.02	N/A	N/A	N/A
Dec 31, 2014	0.02	N/A	N/A	N/A
Sep 30, 2014	0.01	N/A	N/A	N/A
Jun 30, 2014	0.01	N/A	N/A	N/A
Mar 31, 2014	0.01	N/A	N/A	N/A
Dec 31, 2013	0.01	N/A	N/A	N/A
Sep 30, 2013	0.01	N/A	N/A	N/A
Jun 30, 2013	0.02	N/A	N/A	N/A
Mar 31, 2013	0.01	N/A	N/A	N/A
Dec 31, 2012	0.01	N/A	N/A	N/A
Sep 30, 2012	0.01	N/A	N/A	N/A
Jun 30, 2012	0.01	N/A	N/A	N/A
Mar 31, 2012	0.01	N/A	N/A	N/A
Dec 31, 2011	0.01	N/A	N/A	N/A
Sep 30, 2011	0.01	N/A	N/A	N/A
Jun 30, 2011	0.01	N/A	N/A	N/A
Mar 31, 2011	0.01	N/A	N/A	N/A
Dec 31, 2010	0.01	N/A	N/A	N/A
Sep 30, 2010	0.01	N/A	N/A	N/A
Jun 30, 2010	0.01	N/A	N/A	N/A
Mar 31, 2010	0.01	N/A	N/A	N/A
Dec 31, 2009	0.13	N/A	N/A	N/A
Sep 30, 2009	0.01	N/A	N/A	N/A
Jun 30, 2009	0.01	N/A	N/A	N/A
Mar 31, 2009	0.01	N/A	N/A	N/A
Dec 31, 2008	0.01	N/A	N/A	N/A
Sep 30, 2008	0.01	N/A	N/A	N/A
Jun 30, 2008	0.01	N/A	N/A	N/A
Mar 31, 2008	0.01	N/A	N/A	N/A
Dec 31, 2007	0.02	N/A	N/A	N/A
Sep 30, 2007	0.01	N/A	N/A	N/A
Jun 30, 2007	0.01	N/A	N/A	N/A
Mar 31, 2007	0.01	N/A	N/A	N/A
Dec 31, 2006	0.01	N/A	N/A	N/A
Sep 30, 2006	0.01	N/A	N/A	N/A
Jun 30, 2006	0.01	N/A	N/A	N/A
Mar 31, 2006	0.01	N/A	N/A	N/A
Dec 31, 2005	0.01	N/A	N/A	N/A
Sep 30, 2005	0.01	N/A	N/A	N/A
Jun 30, 2005	0.01	N/A	N/A	N/A
Mar 31, 2005	0.01	N/A	N/A	N/A
Mar 31, 2003	0.01	N/A	N/A	N/A
Dec 31, 2002	0.01	N/A	N/A	N/A
Sep 30, 2002	0.01	N/A	N/A	N/A

Balance Sheet (Yearly)

▼

Date	Cash	Total Debt	Total Assets	Total Liabilities	Total Equity
2025-12-31	$290.87M	$N/A	$1.45B	$690.68M	$757.62M
2024-12-31	$264.55M	$N/A	$1.38B	$667.85M	$709.15M
2023-12-31	$270.50M	$N/A	$1.35B	$658.01M	$687.12M
2022-12-31	$157.64M	$N/A	$1.22B	$566.70M	$655.22M
2021-12-31	$137.98M	$N/A	$1.16B	$540.13M	$624.00M
2020-12-31	$158.03M	$N/A	$1.06B	$414.61M	$643.82M
2019-12-31	$120.67M	$N/A	$919.80M	$390.05M	$529.75M
2018-12-31	$98.25M	$N/A	$836.38M	$355.34M	$481.04M
2017-12-31	$96.02M	$N/A	$705.24M	$225.38M	$479.87M
2016-12-31	$114.81M	$N/A	$661.46M	$206.95M	$454.52M
2015-12-31	$143.51M	$N/A	$633.45M	$183.73M	$449.72M
2014-12-31	$18.30M	$N/A	$222.48M	$28.85M	$193.63M
2013-12-31	$18.88M	$N/A	$205.65M	$23.00M	$182.65M
2012-12-31	$14.14M	$N/A	$198.03M	$27.53M	$170.50M
2011-12-31	$8.58M	$N/A	$197.52M	$33.08M	$164.45M
2010-12-31	$24.73M	$N/A	$196.48M	$38.61M	$157.87M
2009-12-31	$27.00M	$N/A	$173.36M	$30.63M	$142.74M
2008-12-31	$18.42M	$N/A	$150.38M	$19.83M	$130.55M
2007-12-31	$9.39M	$N/A	$127.34M	$13.12M	$114.21M
2006-12-31	$54.36M	$N/A	$159.01M	$13.58M	$145.43M

Financial Ratios

▼

Date	Current Ratio	Debt/Equity	Debt/Assets	Interest Coverage	Debt/EBITDA
2025-12-31	2.61x	0.65x	0.48x	5.48x	2.80x
2024-12-31	4.10x	0.72x	0.49x	3.79x	3.38x
2023-12-31	4.06x	0.80x	0.49x	4.44x	4.41x
2022-12-31	2.05x	0.66x	0.46x	10.21x	3.29x
2021-12-31	2.15x	0.64x	0.46x	13.78x	3.29x
2020-12-31	3.06x	0.47x	0.39x	12.54x	2.71x
2019-12-31	1.74x	0.50x	0.42x	9.75x	2.50x
2018-12-31	1.65x	0.51x	0.42x	8.64x	2.64x
2017-12-31	2.93x	0.27x	0.32x	10.88x	1.57x
2016-12-31	3.55x	0.25x	0.31x	6.14x	1.90x
2015-12-31	4.74x	0.27x	0.29x	13.92x	1.68x
2014-12-31	4.58x	0.00x	0.13x	106.79x	0.00x
2013-12-31	5.08x	0.00x	0.11x	130.90x	0.00x
2012-12-31	4.24x	0.03x	0.14x	88.77x	0.13x
2011-12-31	3.77x	0.06x	0.17x	149.76x	0.22x
2010-12-31	3.95x	0.06x	0.20x	71.26x	0.23x
2009-12-31	5.80x	0.04x	0.18x	87.46x	0.15x
2008-12-31	5.92x	0.00x	0.13x	86.91x	0.00x
2007-12-31	7.23x	0.00x	0.10x	25.74x	0.00x
2006-12-31	9.61x	0.00x	0.09x	25.25x	0.00x

Stock Fundamentals

Company Information

Directors & Officers

Shares Statistics

Valuation Metrics

Financial Highlights

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Earnings History

Balance Sheet (Yearly)

Financial Ratios

Watchlist

Assistant